The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

Steven Moylan; Michael Maes; Naomi R. Wray; Michael Berk

doi:10.1038/mp.2012.33

Back

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

Article 2012 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Shared neuroimmune and oxidative pathways underpinning Chagas disease and major depressive disorder

Eduardo Duarte-Silva, Michael Maes, Danielle S. Macêdo, Wilson Savino, Christina Alves Peixoto

Article2025

Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder

Michael Maes, Abbas F. Almulla, Zili You, Yingqian Zhang

Article2018

Serum Interleukin Levels and Insulin Resistance in Major Depressive Disorder

Hussein Kadhem Al‐Hakeim, Sadiq Neama Al-Kufi, Arafat Hussein Al-Dujaili, Michael Maes

Article2018

Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder

Michael Maes, Kamila Landucci Bonifácio, Nayara Rampazzo Morelli, Heber Odebrecht Vargas, Décio Sabbatini Barbosa, André F. Carvalho, Sandra Odebrecht Vargas Nunes

Book2012

Antidepressants and Major Depressive Disorder

Dan Joseph Stein